Amazon (AMZN) says its pharmacy unit will stock Eli-Lilly's (LLY) new weight-loss pill at kiosks and it will also offer same day delivery

Context

Amazon's partnership with Eli Lilly to stock its new weight-loss pill showcases a significant expansion into the pharmaceutical sector, potentially enhancing Amazon's competitive positioning in health and wellness. This collaboration may not only drive traffic to its retail platforms but also signals a strategic move to broaden its offerings in a rapidly growing market segment, which could have positive implications for both companies' growth trajectories.

Trade the TapeGet this analysis live, the moment it breaksNewsquawk's real-time dashboard delivers market-moving headlines and instant context to your desk before the rest of the market reacts.
Open Dashboard
#AMAZON.COM INC#AMZN.US#ELI LILLY & CO#LLY.US#EQUITIES#EU SESSION#US SESSION#BROADLINE RETAIL#PHARMACEUTICALS#BROADLINE RETAIL (GROUP)#PHARMACEUTICALS (GROUP)#CONSUMER DISCRETIONARY DISTRIBUTION & RETAIL#PHARMACEUTICALS, BIOTECHNOLOGY & LIFE SCIENCES#S&P 500 INDEX#NASDAQ 100 INDEX#AMZN#ELI LILLY AND CO#LLY#US EQUITIES
Published: Updated: